Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirzepatide in Obesity and Knee Osteoarthritis
NCT06191848Phase 4Active, not recruiting
- Sponsor
- University of Melbourne
- Start
- Nov 2024
- Primary completion
- May 2027
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of tirzepatide in obesity, knee osteoarthritis (OA), sponsored by University of Melbourne. Started Nov 2024; status: active, not recruiting.
02
Drugs
03
Conditions
obesityknee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06191848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06191848.